AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:31 am Purchase |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
AVORO CAPITAL ADVISORS LLC | 4,988,888 8.200% |
1,233,333 (+32.84%) |
Filing |
| 2024-02-14 09:17 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
AVORO CAPITAL ADVISORS LLC | 3,755,555 6.500% |
655,555 (+21.15%) |
Filing |
| 2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
AVORO CAPITAL ADVISORS LLC | 3,100,000 5.400% |
3,100,000 (New Position) |
Filing |